🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 500mg

Other Ingredients

L-Lysine Monohydrochloride powdered Cellulose Stearic Acid Contains 2% or less of: Ingredients

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (90% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Directions: Adults - Take one tablet daily with food as a dietary supplement.

⚠️ Warnings & Precautions

Safety sealed. Do not use if printed seal under cap is cut, torn, or missing.

Contains: Soy.

Keep out of the reach of children.

Warning: Pregnant or nursing women, individuals taking medication(s) or persons who have a health condition should consult their physician before using this product.

🧪 Formulation Notes

Contains: Soy.

No artificial colors of flavors No gluten ~ No lactose ~ No trans fat

Additional Information

Targeted health

~ Essential for growth & development

Quality value

Store at 15(0) - 30(0)C (59(0) - 86(0)F).

L-Lysine is an amino acid that functions as an essential building block of proteins. L-Lysine Monohydrochloride is an integral part of the amino acid spectrum.

"Satisfaction guaranteed or your money back."

136879 BB786 USA646841

Product Details

UPC / SKU 6 14299 51290 0
DSLD Entry Date 2017-08-22
Product Type Non-Nutrient/Non-Botanical
Form Tablet or Pill
DSLD ID 76744
Data Updated 2026-04-11

Research Evidence

3 Research Sources
74 Avg Quality Score
3 Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013
View all evidence for Lysine →

Compare Similar Products

View all Lysine products →